- Home
- CTMX vs PHUN Comparison
CTMX vs PHUN Comparison
Compare CTMX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTMX | PHUN |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 596.2M | 55.9M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTMX | PHUN |
|---|---|---|
| Price | $4.24 | $1.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 2 |
| Target Price | $6.50 | ★ $7.25 |
| AVG Volume (30 Days) | ★ 3.0M | 178.8K |
| Earning Date | 03-05-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.22 | N/A |
| EPS | ★ 0.24 | N/A |
| Revenue | ★ $113,631,000.00 | $2,357,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $95.95 |
| P/E Ratio | $17.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.40 | $1.77 |
| 52 Week High | $4.66 | $6.00 |
Technical Indicators
Market Signals| Indicator | CTMX | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.73 |
| Support Level | N/A | $1.96 |
| Resistance Level | N/A | $2.05 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 49.02 |
Price Performance
Historical ComparisonAbout CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.